- Home
- MRNA vs IEX Comparison
MRNA vs IEX Comparison
Compare MRNA & IEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- IEX
- Stock Information
- Founded
- MRNA 2010
- IEX 1987
- Country
- MRNA United States
- IEX United States
- Employees
- MRNA N/A
- IEX N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- IEX Fluid Controls
- Sector
- MRNA Health Care
- IEX Industrials
- Exchange
- MRNA Nasdaq
- IEX Nasdaq
- Market Cap
- MRNA 10.6B
- IEX 14.0B
- IPO Year
- MRNA 2018
- IEX 1991
- Fundamental
- Price
- MRNA $24.66
- IEX $183.68
- Analyst Decision
- MRNA Hold
- IEX Buy
- Analyst Count
- MRNA 20
- IEX 8
- Target Price
- MRNA $51.94
- IEX $220.14
- AVG Volume (30 Days)
- MRNA 8.6M
- IEX 722.4K
- Earning Date
- MRNA 05-01-2025
- IEX 05-01-2025
- Dividend Yield
- MRNA N/A
- IEX 1.49%
- EPS Growth
- MRNA N/A
- IEX N/A
- EPS
- MRNA N/A
- IEX 6.30
- Revenue
- MRNA $3,177,000,000.00
- IEX $3,282,600,000.00
- Revenue This Year
- MRNA N/A
- IEX $5.42
- Revenue Next Year
- MRNA $22.14
- IEX $4.59
- P/E Ratio
- MRNA N/A
- IEX $29.49
- Revenue Growth
- MRNA N/A
- IEX 1.66
- 52 Week Low
- MRNA $23.15
- IEX $153.36
- 52 Week High
- MRNA $170.47
- IEX $238.22
- Technical
- Relative Strength Index (RSI)
- MRNA 42.25
- IEX 62.42
- Support Level
- MRNA $23.70
- IEX $179.30
- Resistance Level
- MRNA $28.52
- IEX $186.66
- Average True Range (ATR)
- MRNA 1.34
- IEX 4.64
- MACD
- MRNA -0.03
- IEX 2.12
- Stochastic Oscillator
- MRNA 29.80
- IEX 92.08
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About IEX IDEX Corporation
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2024.